50
Participants
Start Date
August 15, 2023
Primary Completion Date
May 16, 2024
Study Completion Date
May 20, 2024
20mM sodium pyruvate nasal spray
The product is a 20 mM (0.2%, 2.2 mg/mL) sodium pyruvate nasal spray in 0.9% sodium chloride with benzalkonium chloride preservative, pH 7.2 (N115). Subjects will self-administer 3 squirts per nostril of the nasal spray, 3 times daily; upon wakening, noon/midday, and before bedtime.
Saline Placebo control nasal spray
The placebo is 0.9% sodium chloride with benzalkonium chloride preservative, pH 7.2. Subjects will self-administer 3 squirts per nostril of the nasal spray, 3 times daily; upon wakening, noon/midday, and before bedtime.
Family First Medical Research Center, Hialeah Gardens
Lead Sponsor
Family First Medical Research Center
OTHER
Cellular Sciences, inc.
INDUSTRY